Research and Development is a part of our strategy to become an integrated pharmaceutical industry. We believe R&D is of critical importance in our need to grow in the area of biotechnology and original drug research.
One of our key objectives has been to develop indigenous processes for new drugs introduced in the developed countries, produce and introduce them in India and promptly supply them to non-regulatory markets.
Secondly, our emphasis will be on the development and commercialization of generic Active Pharmaceutical Ingredients in line with domestic and international regulatory and quality requirements. Our research efforts are geared to develop innovative (patentable/non-infringing) and cost-effective process know-how for the production of leading APIs and intermediates that are going off patent shortly. For which, we have identified semi-synthetic Macrolides, semi-synthetic Cephalosporins and certain other products in non-antibiotic therapeutic areas.
The aim here is to devise formulations and dosage forms for new drugs to be introduced and to make variants of particular dosage forms. Another objective is to introduce drug combinations by understanding the mechanism of the interaction and the combined effects in increasing intensity of response, in decreasing untoward actions and in altering absorption. The therapeutic range covers Antibiotics, Analgesics, Antihistamines, Antihypertensives, Antidiabetics, Vitamins, Antioxidants, NSAIDs, Psychotropic and Nutritional products.
The development of new delivery systems like liposomes, nanoparticles and controlled drug delivery systems to ensure better compliance, less total drug, efficiency in treatment and economy.